Source: Annual Congress 2002 - Mesothelioma and malignant pleural effusion
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Yatera, T. Kido, T. Kawajiri, C. Yoshii, Y. Morimoto, M. Kido (Kitakyushu City, Japan). Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer. Eur Respir J 2002; 20: Suppl. 38, 1747

Member's Comments

No comment yet.

Related content which might interest you: Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Source: Eur Respir J 2004; 24: 263-266 Year: 2004 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2003; 22: Suppl. 45, 509s Year: 2003 Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013 Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Pleural effusion in lung cancer and targeted therapy Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020 Year: 2021 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Second-line chemotherapy in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Surgery for lung cancer with pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 180s Year: 2002 Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003 Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Bronchoscopic intratumoural therapies for non-small cell lung cancer Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020 Year: 2020 Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004